Pepcid Ac is a drug owned by Kenvue Brands Llc. It is protected by 6 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Feb 26, 2022. Details of Pepcid Ac's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
|
US6814978 (Pediatric) | Process for preparing a soft tablet |
Feb, 2022
(3 years ago) |
Expired
|
| US6814978 | Process for preparing a soft tablet |
Aug, 2021
(3 years ago) |
Expired
|
|
US5854267 (Pediatric) | Method for preventing heartburn |
Jun, 2016
(8 years ago) |
Expired
|
| US5854267 | Method for preventing heartburn |
Dec, 2015
(9 years ago) |
Expired
|
|
US5667794 (Pediatric) | Heartburn treatment |
Nov, 2015
(9 years ago) |
Expired
|
| US5667794 | Heartburn treatment |
May, 2015
(10 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Pepcid Ac is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Pepcid Ac's family patents as well as insights into ongoing legal events on those patents.
Pepcid Ac's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Pepcid Ac's generic launch date based on the expiry of its last outstanding patent is estimated to be Feb 26, 2022 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Pepcid Ac Generic API suppliers:
Famotidine is the generic name for the brand Pepcid Ac. 53 different companies have already filed for the generic of Pepcid Ac, with Annora Pharma having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Pepcid Ac's generic
How can I launch a generic of Pepcid Ac before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Pepcid Ac's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Pepcid Ac's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Pepcid Ac -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 10 mg (OTC) |
Alternative Brands for Pepcid Ac
Pepcid Ac which is used for preventing heartburn episodes caused by consuming heartburn-inducing food or beverages., has several other brand drugs using the same active ingredient (Famotidine). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Horizon |
| |
| Kenvue Brands |
| |
| Ucb Inc |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Famotidine, Pepcid Ac's active ingredient. Check the complete list of approved generic manufacturers for Pepcid Ac
About Pepcid Ac
Pepcid Ac is a drug owned by Kenvue Brands Llc. It is used for preventing heartburn episodes caused by consuming heartburn-inducing food or beverages. Pepcid Ac uses Famotidine as an active ingredient. Pepcid Ac was launched by Kenvue Brands in 1998.
Approval Date:
Pepcid Ac was approved by FDA for market use on 24 September, 1998.
Active Ingredient:
Pepcid Ac uses Famotidine as the active ingredient. Check out other Drugs and Companies using Famotidine ingredient
Treatment:
Pepcid Ac is used for preventing heartburn episodes caused by consuming heartburn-inducing food or beverages.
Dosage:
Pepcid Ac is available in the following dosage forms - tablet form for oral use, tablet, chewable form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 20MG | TABLET, CHEWABLE | Over the counter | ORAL |
| 10MG | TABLET | Over the counter | ORAL |
| 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, CHEWABLE | Discontinued | ORAL |
Pepcid Ac is a drug owned by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jun 29, 2016. Details of Pepcid Ac's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
|
US5854267 (Pediatric) | Method for preventing heartburn |
Jun, 2016
(8 years ago) |
Expired
|
| US5854267 | Method for preventing heartburn |
Dec, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Pepcid Ac is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Pepcid Ac's family patents as well as insights into ongoing legal events on those patents.
Pepcid Ac's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Pepcid Ac's generic launch date based on the expiry of its last outstanding patent is estimated to be Jun 29, 2016 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Pepcid Ac Generic API suppliers:
Famotidine is the generic name for the brand Pepcid Ac. 53 different companies have already filed for the generic of Pepcid Ac, with Annora Pharma having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Pepcid Ac's generic
How can I launch a generic of Pepcid Ac before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Pepcid Ac's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Pepcid Ac's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Pepcid Ac -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 10 mg (OTC) |
Alternative Brands for Pepcid Ac
Pepcid Ac which is used for preventing heartburn episodes caused by consuming heartburn-inducing food or beverages., has several other brand drugs using the same active ingredient (Famotidine). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Horizon |
| |
| Kenvue Brands |
| |
| Ucb Inc |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Famotidine, Pepcid Ac's active ingredient. Check the complete list of approved generic manufacturers for Pepcid Ac
About Pepcid Ac
Pepcid Ac is a drug owned by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div. It is used for preventing heartburn episodes caused by consuming heartburn-inducing food or beverages. Pepcid Ac uses Famotidine as an active ingredient. Pepcid Ac was launched by J And J Consumer Inc in 1999.
Approval Date:
Pepcid Ac was approved by FDA for market use on 05 August, 1999.
Active Ingredient:
Pepcid Ac uses Famotidine as the active ingredient. Check out other Drugs and Companies using Famotidine ingredient
Treatment:
Pepcid Ac is used for preventing heartburn episodes caused by consuming heartburn-inducing food or beverages.
Dosage:
Pepcid Ac is available in tablet form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 10MG | TABLET | Over the counter | ORAL |